Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


Researcher Profiles

On this page, you will find the following:

Daniel Stamer, Ph.D.

Daniel Stamer, Ph.D.

Dr. Daniel Stamer joined the faculty of the University of Arizona as an Assistant Professor in the Department of Ophthalmology and Vision Science in 1998. He set up and directs the university's Glaucoma Research Laboratory. In 2004 he was appointed Associate Head for Vision Science in the College of Medicine to administer research programs in visual development, ophthalmic optics, and neurodegenerative diseases of the eye. Stamer's involvement with BrightFocus began a decade ago, first as a grantee of the National Glaucoma Research (NGR) program and later as a Scientific Review Committee member. Stamer credits the National Glaucoma Research grant program with providing the "support that was essential to help jump start my research program."

The goal of the Stamer laboratory is to better understand how aqueous humor flows out of the eye so that new approaches can be developed to lower intraocular pressure in people with glaucoma.

Back to Top

Dr. Jacque Duncan

Jacque Duncan, M.D., Ph.D.

Dr. Jacque Duncan is a Professor of Clinical Ophthalmology and Director of the Retinal Degenerations Clinic at the University of California,The support we received from AHAF has been critical in pushing our research forward. San Francisco (UCSF). Her expertise is in the diagnosis and management of patients with retinal degenerations, including age-related macular degeneration (AMD), retinitis pigmentosa, cone-rod dystrophy, and Stargardt disease.

BrightFocus' relationship with Dr. Duncan began when she submitted a grant application in the fall of 2008. The following spring, Dr. Duncan was pleased to learn that her project “Why Vision Cells Die In Age-Related Macular Degeneration” was selected for a BrightFocus grant. We're inspired by Dr. Duncan's commitment to researching diseases of the retina, and we're thankful for all of the ways that she has graciously helped BrightFocus. She has starred in two of our public service announcements: Learning About Macular Degeneration at BrightFocuss Children's Corner, and Macular Degeneration: There is Hope that a Cure will be Found.

Right now, her team is building a system to examine cone cells in the UCSF retina clinic. This system will show researchers specific cells that lie beneath vision cells and help keep those vision cells alive. Also, they are studying the genes that increase the risk of AMD to see how they affect the vision cells in people with AMD and in older individuals without AMD.

Back to Top

Daniel Stamer, Ph.D.

Gerard Schellenberg, Ph.D.

Dr. Gerard Schellenberg is a Professor of Pathology and Laboratory Medicine at the University Of Pennsylvania School Of Medicine, and With Alzheimer's disease, our hope is to find new leads and new ideas about where to apply drug research.heads the Alzheimer's Disease Genetics Consortium (ADGC) supported by the National Institute on Aging. The Consortium works with the 29 National Institute on Aging funded Alzheimer's Disease Centers to collect samples for analysis.

Dr. Schellenberg works on the genetics of neurodegenerative diseases and autism, with a particular focus on Alzheimer's disease. Early in his career, his research led to ground-breaking discoveries linked to early-onset familial Alzheimer's disease. Currently, his efforts are focused on the genetics of late-onset dementia, and his work with the ADGC has lead to the discovery of several genes that contribute to the development of Alzheimer's disease.

Dr. Schellenberg has donated his expertise to BrightFocus for some time. In fact, he attributes the BrightFocus grants that he received in the early to mid-nineties as giving him support at a critical time in his career that led to the discovery of one of the genes related to early-onset Alzheimer's disease. BrightFocus is fortunate to have him as a scientific advisor for our Alzheimer's Disease Research program. With the guidance of Dr. Schellenberg and other luminaries on this committee, BrightFocus is able to make well informed decisions about allocating donor funds to research.

He has received awards for his research including: the John Douglas French Foundation for Alzheimer's Disease, Investigator Award in 1986, the Potamkin Prize for Alzheimer's Disease Research, Potamkin Foundation and the American Academy of Neurology in 1994, Metropolitan Life Foundation in Awards for Medical Research in 1995, the Alzheimer's Association Medical Honoree, for outstanding commitment to the research of Alzheimer's disease in 1996, and a Merit Award from the National Institute on Health in 2004.

Back to Top

Last Review: 08/30/13